SCHEMBL18409108

SCHEMBL18409108

CCc1cc(F)cc(F)c1Nc1cc2c(ncn2C)c(NC(=O)C2CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 3/20 0.47
▸ JAK2 O60674 3/20 0.47
▸ TYK2 P29597 3/20 0.47
▸ JAK3 P52333 2/20 0.47
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPY5R Q15761 3/20 0.35
▸ PIK3C3 Q8NEB9 2/20 0.34
▸ MAPK14 Q16539 3/20 0.34
▸ ABL1 P00519 2/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ CHKA P35790 1/20 0.34
▸ WNT1 P04628 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCNA2 P20248 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409285 0.89 TYK2 (0.62) JAK1JAK2TYK2JAK3ABL1
SCHEMBL18409114 0.85 TYK2 (0.46) JAK1JAK2TYK2JAK3PIK3C3
SCHEMBL18409324 0.81 JAK2 (0.59) JAK1JAK2TYK2JAK3NPC1
SCHEMBL18409117 0.81 TYK2 (0.55) JAK1JAK2TYK2JAK3ABL1
SCHEMBL18409202 0.81 TYK2 (0.53) JAK1JAK2TYK2JAK3ABL1
SCHEMBL18409322 0.79 TYK2 (0.53) JAK1JAK2TYK2JAK3ABL1
SCHEMBL18398418 0.79 MAP2K2 (0.38) JAK1JAK2TYK2JAK3MAPK14
SCHEMBL18398421 0.78 JAK2 (0.35) JAK1JAK2TYK2JAK3
SCHEMBL18409103 0.78 JAK2 (0.43) JAK1JAK2TYK2JAK3PIK3C3
SCHEMBL18409286 0.76 JAK2 (0.47) JAK1JAK2TYK2JAK3MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback